97299 ⎘
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen Inducing cell proliferation
IMMUNOMODULATING TUMOR NECROSIS FACTOR RECEPTOR 25 (TNFR25) AGONISTS, ANTAGONISTS AND IMMUNOTOXINS
#602Remedies for pemphigus containing anti-Fas ligand antibodies
#603Nucleic acids encoding monoclonal antibodies to programmed death ligand 1 (PD-L1)
#604Method of using fusion proteins
#605REGULATION OF LYMPHOCYTES AND USES THEREFOR
#606Superagonistic anti-CD28 antibodies
#607Combination of CD137 antibody and CTLA-4 antibody for the treatment of proliferative diseases
#608Method of Promoting Neurogenesis
#609LIGAND FOR HERPES SIMPLEX VIRUS ENTRY MEDIATOR AND METHODS OF USE
#610Humanized monoclonal antibodies and methods of use
#611Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses
#612Anti-AREG/HB-EGF antibodies and treatment
#613Methods of treating cutaneous ulcers and grafts using agonist antibodies to IL-23 receptor
#614Agonistic binding molecules to the human OX40 receptor
#615HVEM/BTLA, HVEM/CD 160 and HVEM/gD cis complexes and methods of use
#616CD40 ANTIBODY FORMULATION AND METHODS
#617LYMPHOCYTE CONTROL OF OBESITY AND INSULIN RESISTANCE
#618Therapeutic Binding Molecules
#619AAV VECTOR COMPOSITIONS AND METHODS FOR ENHANCED EXPRESSION OF IMMUNOGLOBULINS USING THE SAME
#620DENDRITIC CELL POTENTIATION
#621Immunoconjugates Comprising Poxvirus-Derived Peptides and Antibodies Against Antigen-Presenting Cells for Subunit-Based Poxvirus Vaccines
#622Targeted immunoconjugates
#623ANTIBODY HAVING AN IMMUNE-ENHANCEMENT FUNCTION
#624Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling
#625CADHERIN-11 ANTAGONISTS AND METHODS FOR THE TREATMENT OF INFLAMMATORY JOINT DISORDERS
#626Methods and Compositions for Localized Secretion of Anti-CTLA-4 Antibodies
#627Method for producing human antibodies with properties of agonist, antagonist, or inverse agonist
#628Human immune therapies using a CD27 agonist alone or in combination with other immune modulators
#629Antibodies to TGFβ
#630Cadherin-11 EC1 domain antagonists for treating inflammatory joint disorders
#631NUCLEOTIDE AND PROTEIN SEQUENCE OF MAMMASTATIN AND METHODS OF USE
#632DR4 ANTIBODIES AND USES THEREOF
#633DNA encoding a soluble fragment of TRAIL polypeptide
#634Methods for Improving Immune Function and Methods for Prevention or Treatment of Disease in a Mammalian Subject
#635Use of soluble CEACAM8 for diagnosing, treating or monitoring diseases, and a method for screening compounds that prevent apoptosis
#636DISEASE TREATMENT VIA ANTIMICROBIAL PEPTIDE INHIBITORS
#637IMMUNE SYSTEM PROGRAMMING THROUGH B7-DC
#638Anti-CD40 targeted fusion proteins
#639ANTI-DLL4 ANTIBODIES AND METHODS USING SAME
#640Fusion protein with HIV antigen
#641Anti-CD38 human antibodies and uses thereof
#642Antibodies against human NKG2D and uses thereof
#643IMMUNOCOMPETENT CELL HAVING ANTI-CD38 ANTIBODY ON ITS CELL SURFACE
#644USE OF A CD28 BINDING PHARMACEUTICAL SUBSTANCE FOR MAKING A PHARMACEUTICAL COMPOSITION WITH DOSE-DEPENDENT EFFECT
#645Methods of promoting antitumor immunity by administering CD40 agonists and alpha-galactosyl ceramide
#646Anti-CD40 antibodies
#647ANTIBODIES THAT BIND TO AN EPITOPE ON THE HUNTINGTON'S DISEASE PROTEIN
#648HUMAN ANTIBODIES AGAINST HUMAN FAS AND THEIR USE
#649Immune modulation via C-type lectin
#650WISP POLYPEPTIDES AND NUCLEIC ACIDS ENCODING SAME
#651Methods and compositions for modulating wound repair
#652Anti-PD-L1 antibodies, compositions and articles of manufacture
#653Novel Compositions And Methods For Stimulating Erythropoiesis In A Mammal
#654AGONIST ANTI-TRKB MONOCLONAL ANTIBODIES
#655Anti-CD3 antibodies and methods of use thereof
#656Superagonistic anti-CD28 antibodies
#657Methods for the treatment of infections and tumors
#658KIM-1 antibodies for treatment of TH2-mediated conditions
#659Interferon alpha receptor I antibodies and their use
#660CONSTRUCTION AND USE OF A FUNCTIONALLY HUMAN ANTIBODY LIBRARY WITH MAXIMIZED REPERTOIRE DIVERSITY
#661TGF-beta binding antibodies
#662Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer
#663METHODS OF MODULATING HVEM, BTLA AND CD160 CIS COMPLEX RESPONSE OR SIGNALING ACTIVITY WITH SOLUBLE LIGHT POLYPEPTIDE SEQUENCES
#664COMPOSITIONS AND METHODS FOR MODULATING VASCULAR DEVELOPMENT
#665Light targeting molecules and uses thereof
#666Monoclonal antibody and use thereof
#667Antibodies against RAMP3
#668TCR-independent activation of T cells
#669Antibodies against human NKG2D and uses thereof
#670NERVE ELONGATION PROMOTER AND ELONGATION INHIBITOR
#671Rationally designed antibodies
#672Methods of using TGF-β 1 binding compositions
#673Antibodies to c-Met
#674Agents for Promoting the Growth of Hematopoietic Stem Cells
#675HUMAN EPO MIMETIC HINGE CORE MIMETIBODIES, COMPOSITIONS, METHODS AND USES FOR PREVENTING OR TREATING GLUCOSE INTOLERANCE RELATED CONDITIONS ON RENAL DISEASE ASSOCIATED ANEMIA
#676ANTI-AMYLOID ANTIBODIES, COMPOSITIONS, METHODS AND USES
#677Compositions and methods of use for therapeutic antibodies
#678DENDRITIC CELL POTENTIATION
#679DENDRITIC CELL POTENTIATION
#680Agonist antibody to human thrombopoietin receptor
#681Interferon alpha antibodies and their uses
#682VASCULAR ENDOTHELIAL GROWTH FACTOR-2
#683NOVEL TNF RECEPTOR REGULATORY DOMAIN
#684CD40 ANTIBODY FORMULATION AND METHODS
#685Methods for predicting patient response to modulation of the Co-stimulatory pathway
#686BINDING PARTNERS WITH IMMUNOGLOBULIN DOMAINS MODIFIED TO HAVE EXTENDED HALF-LIFE
#687Compositions and methods for the diagnosis and treatment of immune disorders
#688Method for producing human antibodies to a self physiological receptor by site-directed in vitro immunization of human lymphocytes
#689NOVEL MEMORY CTL INDUCTION POTENTIATOR
#690Agonist antibodies to IL-23 receptor
#691METHODS FOR TREATING AUTOIMMUNE DISORDERS
#692TRANS-MEMBRANE-ANTIBODY INDUCED INHIBITION OF APOPTOSIS
#693CD30 Ligand
#694Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders
#695ERYTHROPOIETIN RECEPTOR BINDING ANTIBODIES
#696USES OF BISPECIFIC ANTIBODY COATED DENDRITIC CELLS PULSED WITH ANTIGENS AND GM-CSF IN IMMUNE REGULATION
#697MUC1 EXTRACELLULAR DOMAIN AND CANCER TREATMENT COMPOSITIONS AND METHODS DERIVED THEREFROM
#698Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
#699Novel Method to Increase Memory T Lymphocytes and Enhance Their Functions
#700Treatment of Conditions Involving Demyelination
#701METHODS FOR TREATING HIV INFECTED SUBJECTS
#702TGF-BETA BINDING ANTIBODIES
#703Anti-CD40 antibodies capable of blocking B-cell activation
#704Use of TRAIL polypeptides to induce apoptosis
#705Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors
#706Orally Deliverable and Anti-Toxin Antibodies and Methods for Making and Using Them
#707Pharmaceutical compositions comprising an anti-teratogenic compound and applications of the same
#708Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
#709Composition comprising humanized antibody HBBK4 for the treatment of cancer and the use thereof
#710TGF-β binding antibodies
#711Activation of Human Antigen-Presenting Cells Through CLEC-6
#712Death domain containing receptor 5
#713Therapeutic Applications of Activation of Human Antigen-Presenting Cells Through Dectin-1
#714COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY LUNG DISEASE
#715Methods for specifically selecting antibody-producing cells
#716Nucleotide and protein sequence of Mammastatin and methods of use
#717Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
#718DENDRITIC CELL POTENTIATION
#719Antibodies which activate an erythropoietin receptor
#720Trimeric collagen scaffold antibodies
#721Anti-DLL4 antibodies and methods using same
#722Methods of treating cutaneous ulcers and grafts using IL-23
#723Immune-derived moieties reactive against lysophosphatidic acid
#724Immune-Derived Moieties Reactive Against Bioactive Lipids, and Methods of Making and Using Same
#725Leptin antagonist and method for quantitative measurement of leptin
#726ANTIBODIES THAT BIND TO AN EPITOPE ON THE HUNTINGTON'S DISEASE PROTEIN
#727ERYTHROPOIETIN RECEPTOR BINDING ANTIBODIES
#728DR4 antibodies and uses thereof
#729Somatic transgene immunization and related methods
#730Antibodies to TGF-beta 1
#731Antibodies to Erythropoietin Receptor and Uses Thereof
#732HUMANIZED ANTIBODIES AGAINST CD3
#733COMPOSITIONS AND METHODS FOR MODULATING VASCULAR DEVELOPMENT
#734B7S1: an immune modulator
#735Compositions and methods for treating inflammatory lung disease
#736Ligand for herpes simplex virus entry mediator and methods of use
#737Method of stimulating proliferation of regulatory T cells in a diabetic mammal
#738Methods of Screening for Modified Antibodies With Agonistic Activities
#739TWEAK as a therapeutic target for treating central nervous system diseases associated with cerebral edema and cell death
#740Methods for decreasing immune response and treating immune conditions
#741Antibodies to TGF-beta
#742Methods of targeting multiple cytokines
#743NATURAL KILLER CELL COMPOSITIONS AND METHOD FOR PRODUCTION OF THE SAME
#744Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
#745Methods of upmodulating an immune response with non-activating forms of B7-4
#746Uses of bispecific antibody coated dendritic cells pulsed with antigens and GM-CSF in immune regulation
#747LYMPHOCYTES; METHODS
#748Humanized anti-CD3 specific antibodies
#749Method for inducing differentiation of regulatory t cells usinggip-anchored protein agonist and pharmaceutical composition therefor ( as amended
#750Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
#751Humanized anti-CD3 specific antibodies
#752Antibodies to TGF-BETA
#753Humanized anti-CD3 specific antibodies
#754Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins
#755Use of an active substance binding to CD28 for producing a pharmaceutical composition for the treatment of B-CLL
#756Methods and compositions for the treatment of persistent infections
#757Nucleotide and protein sequence of mammastatin and methods of use
#758Chimeric mouse having an immune system constructed with human CD34+ cells and use thereof
#759Molecular determinants of myeloma bone disease and use thereof
#760Compositions and methods for the diagnosis and treatment of immune disorders
#761WISP polypeptides and nucleic acids encoding same
#762Antibodies as chimeric effector cell receptors against tumor antigens
#763Antibodies which activate an erythropoietin receptor
#764Anti-interferon alpha antibodies
#765Dendritic cell expanded T suppressor cells and methods of use thereof
#766Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
#767Nucleic acids encoding superagonistic anti-CD28 antibodies
#768Antibody to the human OX40 receptor
#769Humanized anti-CD3 specific antibodies
#770Antibodies to TGF-β
#771Compositions comprising a first agent which provides a primary activation signal to T cells and a second agent which stimulates an accessory molecule on the surface of T cells
#772Anti-CD3 antibodies and methods of use thereof
#773Agonist antibodies
#774Methods for Treating Autoimmune Disorders
#775Techniques and compositions for diagnosis and treatment of cancer (muci)
#776Humanized anti-CD3 specific antibodies
#777Humanized anti-CD3 specific antibodies
#778Humanized anti-CD3 specific antibodies
#779Process for producing human-origin immunocompetent cell
#780Promotion of central nervous system remyelination using monoclonal autoantibodies
#781Fibroblast growth factor receptors and methods for their use
#782Disease treatment via antimicrobial peptide inhibitors
#783Methods for selectively enriching TH1 and TH2 cells
#784Humanized anti-CD3 specific antibodies
#785Therapeutic binding molecules
#786Sialoadhesin factor-3 antibodies
#787AAV vector compositions and methods for enhanced expression of immunoglobulins using the same
#788Interferon alpha receptor 1 antibodies and their uses
#789Methods of using human receptor protein 4-1BB
#790Antibodies to erythropoietin receptor and uses thereof
#791Methods for treating HIV infected subjects
#792Use of a CD28 binding pharmaceutical substance for making a pharmaceutical composition with dose-dependent effect
#793Use of an active substance binding to CD28 for producing a pharmaceutical composition for the treatment of B-CLL
#794Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
#795Trypanosome derived apoptotic factors (TAF)
#796Method for producing human antibodies to human CD152 with properties of agonist, antagonist, or inverse agonist
#797Compositions and methods for regulating lymphocyte activation
#798Cripto-specific antibodies
#799Dendritic cell potentiation
#800Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
#801Modified antibody variable domains
#802Antibodies to erythropoietin receptor and uses thereof
#803Agonist antibodies
#804Methods and compositions for regeneration of aged skeletal muscle tissues
#805Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
#806Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodies
#807Anti-CD40 antibodies capable of blocking B-cell activation
#808Modified rapid expansion methods ("modified-REM") for in vitro propagation of T lymphocytes
#809B7S1: an immune modulator
#810Method of using a cytokine that induces apoptosis
#811Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases
#812IL-23p40 specific antibody
#813CD40 antibody formulation and methods
#814Treatment of rheumatoid arthritis with CD99 antagonists
#815Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases
#816Therapeutic binding molecules
#817Antibodies to c-Met
#818Uses of an endothelial cell receptor
#819MUC1 extracellular domain and cancer treatment compositions and methods derived therefrom
#820Lymphocytes; methods
#821MUC1 extracellular domain and cancer treatment compositions and methods derived therefrom
#822Methods for inhibiting lymphotoxin β receptor signalling
#823Trans-membrane-antibody induced inhibition of apoptosis
#824Treatment of central nervous system diseases by antibodies against glatiramer acetate
#825Monoclonal antibodies specific to VEGF receptors and uses thereof
#826Antibodies binding PD-1 and uses thereof